← Leaderboards
David P Richman
University Of California At Davis
$641,851
Attributed
$866,050
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $250.9K · FY2010–19$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$866,050 · 2
By mechanism
R21$866,050 · 2
Top collaborators
- Michael C. Milone2 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Ricardo Anibal Maselli$2,447,218
- Peter Belafsky$1,274,096
- David G Amaral$36,802,574
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorCholinergic ReceptorsMyasthenia GravisSynapsesAnimal ModelImmune SystemImmuneMyastheniaNeuromuscular JunctionSpleenRattusNeuromuscularAnimalsMediatingAntibodiesAutopsyAutoimmune ResponsesAutoimmune ProcessAutoimmune DiseasesAnimal Model DevelopmentAdverse EffectsCellsCessation Of LifeCell Model
Grant awards (4)
Antigen-specific treatment of myasthenia gravis: Chimeric autoantibody receptor T cells targeting autoimmune B cells$197,456
R21 · FY2019 · NS · contact PI
Antigen-specific treatment of myasthenia gravis: Chimeric autoantibody receptor T cells targeting autoimmune B cells$250,942
R21 · FY2018 · NS · contact PI
Development of Animal Models of Anti-MuSK Myasthenia$188,089
R21 · FY2011 · NS · contact PI
Development of Animal Models of Anti-MuSK Myasthenia$229,563
R21 · FY2010 · NS · contact PI